Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director | May 13, 2026 | May 14, 2026 |
| IPG PHOTONICS CORPIPGP · Entity 1767 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,539 |
Reported balance
After 2026-05-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 4,539 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-05-13 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13 | Direct | 1,475 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are Restricted Stock Units.
F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.
F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.
IPG PHOTONICS CORP
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,513 |
Reported balance
After 2026-05-12 transaction · row 1
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 2,436 · Balance 11,513 F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 29,249 · Balance 0 F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting. F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.68 · Expires 2025-02-08 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 1,630 · Balance 0 F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.73 · Expires 2026-02-14 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 6,002 · Balance 0 F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.59 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 14,122 · Balance 0 F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 1,063 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-15 · Disposition to issuer · Disposed 12,103 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-15 · Disposition to issuer · Disposed 1,906 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-15 · Disposition to issuer · Disposed 8,859 · Balance 0 F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-04-15 · Disposition to issuer · Disposed 10,777 · Balance 0 F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.
F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock.
F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 1,751 | $121.87 | $213,394.37 |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,175 F2 · shares: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,683 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,237 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 18:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 8,390 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-18-005613 · form4.xml · derivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,780 Underlying: Common Stock · 8,390 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 18:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 2,566 | $117.14 | $300,592.27 |
DisclosureSEC source: 0001127602-18-005613 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 2,566 shares were sold in multiple transactions executed on the same day at prices ranging from $116.90 to $117.56. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 18:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 3,624 | $116.57 | $422,437.00 |
DisclosureSEC source: 0001127602-18-005613 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,228 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 3,624 shares were sold in multiple transactions executed on the same day at prices ranging from $115.90 to $116.89. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 18:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 2,200 | $115.52 | $254,134.54 |
DisclosureSEC source: 0001127602-18-005613 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,852 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 2,200 shares were sold in multiple transactions executed on the same day at prices ranging from $114.87 to $115.82. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 18:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 8,390 | $80.40 | $674,556.00 |
DisclosureSEC source: 0001127602-18-005613 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 15:50 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 3,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005148 · form4.xml · derivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,699 Underlying: Common Stock · 3,723 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 15:50 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 19,553 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-18-005148 · form4.xml · derivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,553 Underlying: Common Stock · 19,553 shares Expires 2025-02-08 F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 18:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 933 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-18-001991 · form4.xml · derivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932 Underlying: Common Stock · 933 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 18:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 833 | $108.39 | $90,288.29 |
DisclosureSEC source: 0001127602-18-001991 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 833 shares were sold in multiple transactions executed on the same day at prices ranging from $108.15 to $108.96. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 18:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 100 | $107.68 | $10,768.00 |
DisclosureSEC source: 0001127602-18-001991 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,495 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 18:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 933 | $81.97 | $76,478.01 |
DisclosureSEC source: 0001127602-18-001991 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,089 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-18-001854 · form4.xml · derivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,143 Underlying: Common Stock · 1,089 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 800 | $108.43 | $86,744.00 |
DisclosureSEC source: 0001127602-18-001854 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 800 shares were sold in multiple transactions executed on the same day at prices ranging from $108.19 to $108.75. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 189 | $107.74 | $20,362.86 |
DisclosureSEC source: 0001127602-18-001854 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,462 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 100 | $107.16 | $10,716.00 |
DisclosureSEC source: 0001127602-18-001854 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,651 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,089 | $67.12 | $73,093.68 |
DisclosureSEC source: 0001127602-18-001854 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| December 13, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 931 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · derivative · entry 8 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,865 Underlying: Common Stock · 931 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F7 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 13, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 500 | $113.44 | $56,719.00 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · nonDerivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · price: The 500 shares were sold in multiple transactions executed on the same day at prices ranging from $113.04 to $113.94. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 13, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 431 | $112.51 | $48,490.65 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · nonDerivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,162 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 431 shares were sold in multiple transactions executed on the same day at prices ranging from $112.09 to $112.86. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 13, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 931 | $81.97 | $76,314.07 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,087 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · derivative · entry 7 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,232 Underlying: Common Stock · 1,087 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F6 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 887 | $111.19 | $98,623.40 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 887 shares were sold in multiple transactions executed on the same day at prices ranging from $110.76 to $111.68. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 200 | $110.66 | $22,131.00 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,549 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 200 shares were sold in multiple transactions executed on the same day at prices ranging from $110.64 to $110.67. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 20:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,087 | $67.12 | $72,959.44 |
DisclosureSEC source: 0001127602-17-034608 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,088 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · derivative · entry 8 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,319 Underlying: Common Stock · 1,088 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F8 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 933 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · derivative · entry 7 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,796 Underlying: Common Stock · 933 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F7 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 688 | $107.70 | $74,095.88 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · nonDerivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · price: The 688 shares were sold in multiple transactions executed on the same day at prices ranging from $107.31 to $108.01. The detailed breakdown of executed sales will be furnished upon request. F6 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 62 shares purchased on October 27, 2017 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 400 | $106.82 | $42,729.00 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · nonDerivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,350 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 400 shares were sold in multiple transactions executed on the same day at prices ranging from $106.72 to $106.92. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,088 | $67.12 | $73,026.56 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 633 | $107.62 | $68,126.31 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 633 shares were sold in multiple transactions executed on the same day at prices ranging from $107.06 to $107.94. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 300 | $106.77 | $32,031.99 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,295 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 300 shares were sold in multiple transactions executed on the same day at prices ranging from $106.59 to $106.89. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 933 | $81.97 | $76,478.01 |
DisclosureSEC source: 0001127602-17-032109 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| October 18, 2017 Filed Oct 19, 2017 20:26 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 931 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-030088 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 Underlying: Common Stock · 931 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| October 18, 2017 Filed Oct 19, 2017 20:26 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 931 | $105.00 | $97,755.00 |
DisclosureSEC source: 0001127602-17-030088 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| October 18, 2017 Filed Oct 19, 2017 20:26 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 931 | $81.97 | $76,314.07 |
DisclosureSEC source: 0001127602-17-030088 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 15:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,088 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-029805 · form4.xml · derivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,407 Underlying: Common Stock · 1,088 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 15:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 988 | $101.61 | $100,394.24 |
DisclosureSEC source: 0001127602-17-029805 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 988 shares were sold in multiple transactions executed on the same day at prices ranging from $101.19 to $101.98. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 15:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 100 | $100.95 | $10,095.00 |
DisclosureSEC source: 0001127602-17-029805 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,588 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 15:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,088 | $67.12 | $73,026.56 |
DisclosureSEC source: 0001127602-17-029805 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 11:36 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 933 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-027420 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,660 Underlying: Common Stock · 933 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 11:36 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 933 | $107.29 | $100,100.08 |
DisclosureSEC source: 0001127602-17-027420 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 933 shares were sold in multiple transactions executed on the same day at prices ranging from $106.96 to $107.64. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 11:36 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 933 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-027420 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 20:40 UTC Amendment | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 933 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-027791 · form4a.xml · derivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,660 Underlying: Common Stock · 933 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 20:40 UTC Amendment | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 933 | $81.97 | $76,478.01 |
DisclosureSEC source: 0001127602-17-027791 · form4a.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The amended Form 4 is being filed to disclose the acquisition price of the Common Stock. The shares were acquired by exercising Non-Qualified Stock Options, and the acquisition price is the exercise price of the Non-Qualified Stock Option. The original Form 4 inadvertently disclosed that the shares were acquired at a price of $0; however, the exercise price of the Non-Qualified Stock Option was properly stated in Table II as $81.97. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 11:25 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,088 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-027364 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,495 Underlying: Common Stock · 1,088 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 11:25 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,088 | $107.33 | $116,777.65 |
DisclosureSEC source: 0001127602-17-027364 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 1,088 shares were sold in multiple transactions executed on the same day at prices ranging from $106.86 to $107.61. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.